107 related articles for article (PubMed ID: 18340677)
1. Improving outcomes through collaboration.
Thiboutot DM; Harper JC; O'Connell K; Rich P; Sondheimer SJ
Cutis; 2008 Jan; 81(1 Suppl):26-31. PubMed ID: 18340677
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acne with oral contraceptives: criteria for pill selection.
Koulianos GT
Cutis; 2000 Oct; 66(4):281-6. PubMed ID: 11109151
[TBL] [Abstract][Full Text] [Related]
3. Hormonal contraceptives for acne management.
Rich P
Cutis; 2008 Jan; 81(1 Suppl):13-8. PubMed ID: 18338653
[TBL] [Abstract][Full Text] [Related]
4. [Cutaneous effects in hormonal contraception].
Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and the management of hyperandrogenism-polycystic ovary syndrome in adolescents.
Hillard PJ
Endocrinol Metab Clin North Am; 2005 Sep; 34(3):707-23, x. PubMed ID: 16085167
[TBL] [Abstract][Full Text] [Related]
6. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
7. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
8. Skin improvement with two different oestroprogestins in patients affected by acne and polycystic ovary syndrome: clinical and instrumental evaluation.
Colonna L; Pacifico V; Lello S; Sorge R; Raskovic D; Primavera G
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1364-71. PubMed ID: 22011217
[TBL] [Abstract][Full Text] [Related]
9. Syndromes of hyperandrogenism in women.
Davis S
Aust Fam Physician; 1999 May; 28(5):447-51. PubMed ID: 10376368
[TBL] [Abstract][Full Text] [Related]
10. [Dermatological complications caused by oral contraceptives].
Deharo C; Berbis P; Privat Y
Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
[TBL] [Abstract][Full Text] [Related]
11. Acne and oral contraceptives: update on women's health screening guidelines.
Frangos JE; Alavian CN; Kimball AB
J Am Acad Dermatol; 2008 May; 58(5):781-6. PubMed ID: 18359534
[TBL] [Abstract][Full Text] [Related]
12. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
13. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
Batzer FR
J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
[TBL] [Abstract][Full Text] [Related]
14. Acne in the adult female patient: a practical approach.
Kamangar F; Shinkai K
Int J Dermatol; 2012 Oct; 51(10):1162-74. PubMed ID: 22994662
[TBL] [Abstract][Full Text] [Related]
15. Hormonal therapy for acne: why not as first line therapy? facts and controversies.
Katsambas AD; Dessinioti C
Clin Dermatol; 2010; 28(1):17-23. PubMed ID: 20082945
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptive containing chlormadinone acetate and ethinylestradiol reduces plasma concentrations of matrix metalloproteinase-2 in women with polycystic ovary syndrome.
Gomes VA; Vieira CS; Jacob-Ferreira AL; Belo VA; Soares GM; França JB; Ferriani RA; Tanus-Santos JE
Basic Clin Pharmacol Toxicol; 2012 Sep; 111(3):211-6. PubMed ID: 22510229
[TBL] [Abstract][Full Text] [Related]
17. Dermatology of androgen-related disorders.
Essah PA; Wickham EP; Nunley JR; Nestler JE
Clin Dermatol; 2006; 24(4):289-98. PubMed ID: 16828411
[TBL] [Abstract][Full Text] [Related]
18. The effect of pharmaceutical intervention on lipid profile in polycystic ovary syndrome.
Diamanti-Kandarakis E; Kandaraki E; Christakou C; Panidis D
Obes Rev; 2009 Jul; 10(4):431-41. PubMed ID: 19413702
[TBL] [Abstract][Full Text] [Related]
19. Acne-associated syndromes: models for better understanding of acne pathogenesis.
Chen W; Obermayer-Pietsch B; Hong JB; Melnik BC; Yamasaki O; Dessinioti C; Ju Q; Liakou AI; Al-Khuzaei S; Katsambas A; Ring J; Zouboulis CC
J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):637-46. PubMed ID: 21198949
[TBL] [Abstract][Full Text] [Related]
20. Ovarian morphology and prevalence of polycystic ovary syndrome in reproductive aged women with or without mild acne.
Kelekci KH; Kelekci S; Incki K; Ozdemir O; Yilmaz B
Int J Dermatol; 2010 Jul; 49(7):775-9. PubMed ID: 20618496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
